GE HEALTHCARE HOLDING NORGE AS

Operating

Produksjon, handel og legemiddelproduksjon og virksomhet som står i forbindelse med dette, herunder finansiering av nærstående parter, samt deltagelse i andre selskaper og foretak.

Produksjon, handel og legemiddelproduksjon og virksomhet som står i forbindelse med dette, samt deltagelse i andre selskaper og foretak.

Keywords

productionmedicinal substancesdrugsantibioticsbasic vitaminssalicylic acido-acetylsalicylic acidprocessing of blood

Organization

CEO: JS
Jostein Strømmesen1984
Chairman of the board: JS
Jostein Strømmesen1984
Years since formation: 20 years; since Nov 24, 2005
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 10,041,000; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Annual total result 2024: 2,817,479,000; NOK
Total equity 2024: 14,048,318,000; NOK

Last update: Sep 9, 2025

Management

Management / administration

Name	Role	Shares
JS Jostein Strømmesen 1984	Managing Director/CEO	-

Board

Name	Role	Shares
JS Jostein Strømmesen 1984	Chairman	-
SD Sejal Dhillon 1963	Board Member	-
GG Georg Grøndalen 1983	Board Member	-

Others

Name	Role	Shares
D DELOITTE AS	Auditor	-

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
G GE HEALTHCARE CLINICAL SYSTEMS NORWAY AS	Ordinary shares	10,041,000	100 %

Shares owned by the GE HEALTHCARE HOLDING NORGE AS

Name	Share class	Total number of shares	Share
G GE HEALTHCARE EN AS Closed	Ordinary shares	262,200	100 %
G GE HEALTHCARE AS	Ordinary shares	1,000,000	100 %

Last update: Jun 2, 2025

Group structure

GE HEALTHCARE HOLDING AS
Total operating income 2024: NOK 0
Operating profit 2024: NOK 0
Employees: 0

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Annual Total Result	2,817,479,000	2,577,189,000	4,946,114,000	3,822,954,000
Total assets	15,700,636,000	14,370,137,000	14,498,522,000	14,632,183,000
Total liabilities	1,652,318,000	1,081,798,000	1,920,227,000	7,000,001,000
Total equity	14,048,318,000	13,288,339,000	12,578,296,000	7,632,182,000

P&L

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Total operating costs	105,000	88,000	0	0
Operating result	-105,000	-88,000	0	0
Financial income/costs	3,070,714,000	2,577,277,000	4,946,114,000	3,822,954,000
Profit before tax	3,070,609,000	2,577,189,000	4,946,114,000	3,822,954,000
Total tax & extraordinary income/cost	253,130,000	0	0	0
Annual Total Result	2,817,479,000	2,577,189,000	4,946,114,000	3,822,954,000

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	14,279,837,000	14,370,137,000	14,498,522,000	14,498,522,000
Total current assets	1,420,799,000	0	0	133,661,000
Total assets	15,700,636,000	14,370,137,000	14,498,522,000	14,632,183,000
Short term debt	1,652,318,000	1,081,798,000	1,920,227,000	7,000,001,000
Long term debt	0	0	0	0
Total liabilities	1,652,318,000	1,081,798,000	1,920,227,000	7,000,001,000
Contributed capital	7,632,182,000	7,632,182,000	7,632,182,000	7,632,182,000
Retained earnings	6,416,136,000	5,656,157,000	4,946,114,000	0
Total equity	14,048,318,000	13,288,339,000	12,578,296,000	7,632,182,000
Total equity and liabilities	15,700,636,000	14,370,137,000	14,498,522,000	14,632,183,000

Classification

21st company classification

BETA

Individual SMB enterprise

GE HEALTHCARE HOLDING NORGE AS988 963 755